Stockholm, September 20, 2024 - Intervacc AB (publ) predicts that the vaccine Strangvac®, which is approved for sale in Europe and the UK, may be out-of-stock for a short period from the 1st October 2024. The ... Read more
Stockholm, September 20, 2024 – Intervacc AB (publ) announces that the application for supplementary protection for Strangvac®, an innovative vaccine against strangles, has now been approved in the United ... Read more
The Group in summary
Read moreStockholm, August 20, 2024 – Some of Europe's foremost strangles experts have compiled and published an article in which experiences from the use of Strangvac® are discussed. The article was published in ... Read more
Stockholm, August 15, 2024 –Intervacc AB (publ) and the Karolinska Institute, KI, announce that they have extended their collaboration to develop a new generation of animal health vaccines using recombinant fusion ... Read more
